Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Trial Evaluating the Safety, Tolerability, Efficacy and Pharmacokinetic Profile of Tacrolimus Inhalation Powder in Adult Lung Transplant Recipients

NCT05501574 is registered in ClinicalTrials.gov with TFF Pharmaceuticals, Inc. as lead sponsor.

NCT NCT05501574
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05501574 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Trial Evaluating the Safety, Tolerability, Efficacy and Pharmacokinetic Profile of Tacrolimus Inhalation Powder in Adult Lung Transplant Recipients
Lead sponsor
TFF Pharmaceuticals, Inc.
Phase
Phase 2
Overall status
Terminated
Start date
April 18, 2023
Completion date
December 23, 2024
Enrollment
14 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

lung transplant rejection